Global OTC drug market projected to grow to US$410.5B by 2030, with CAGR growth of 8.2% from 2022-2030; growth driven by increased focus on maintaining health, use of OTC drugs to treat common illnesses

Sample article from our Tissue & Hygiene

August 1, 2022 (press release) –

 The Global Over-the-Counter Drugs Market is expected to clock ~US$ 410.48 billion by 2030 owing to the growing incidence of seasonal infections and new OTC drug launched by companies in the market.

The growing focus of the population on staying healthy and increasing adoption of OTC drugs to treat common illnesses are some of the key factors, propelling the growth of the OTC drugs market. Many pharmaceutical and nutraceutical companies are focused on developing and launching new drugs.

Request a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/over-the-counter-drugs-market/7735

Key takeaways from the Over-The-Counter Drugs Market Report In January 2021, Hamdard Laboratories launched 12 new OTC drugs in the Indian market for encouraging immunity. The new product range comprises herbal ingredients. The company also announced health vans for contribution-free samples of these products and discussions by experts. Major players operating in telemedicine market report are Johnson & Johnson, Novartis AG, Teva Pharmaceuticals, GlaxoSmithKline plc, Bayer AG, PGT Healthcare, Pfizer Inc., Boehringer Ingelheim, Merck KGaA, Reckitt Benckiser Group PLC., Glenmark Pharmaceuticals Ltd., Sanofi-Aventis U.S. LLC, and Takeda Pharmaceutical Company Limited, among others.In April 2020, Takeda Pharmaceuticals entered into an agreement with Orifarm Group, a Danish pharmaceutical company to divest a portfolio of select non-core OTC and prescription pharmaceutical products sold in Europe.

The global over-the-counter drugs market has been analyzed from two perspectives: product, distribution channels, and region.

To read more about the latest highlights related to OTC Drug, get a snapshot of the key highlights entailed in the global over-the-counter drugs market

Excerpts from By Product Segmentation

Based on product types, the global over the over-the-counter drugs market has been segmented into: Analgesics & Pain RelieversCoughCold & Flu ProductsVitamin & Mineral Supplements (VMS)Gastrointestinal ProductsDermatological ProductsOphthalmic ProductsSleep AidsWeight Loss/Dietary SupplementsSmoking Cessation AidsOthers

Weight loss and VMS OTC drugs make up a large portion of the market, nearly one-fourth of the market belongs to this segment. Unlike other, more intense conditions, VMS and weight loss are not particularly critical. OTC products for these conditions are more precautionary than therapeutic or curative. As a result, the number of customers is relatively higher than for other indicators. Large customer bases generate high demand, which leads to high revenue generation. Because of the growing health problem of the population in developed countries, VMS products are extremely popular. In addition, as a result of the coronavirus disease (COVID-19) outbreak, people are becoming more aware of the importance of self-care. This, in turn, increased sales of nutritional supplements and boosted the market growth. Analgesics, on the other hand, are expected to grow rapidly during the forecast period. This is due to an aging population driving up demand for pain relievers, as well as the introduction of new over-the-counter (OTC) drugs and pain relievers. The desire to improve healthcare outcomes drives the global demand for analgesics. This includes pain management, which, in order to be effective, requires a multidisciplinary approach.

Excerpts from By Region Segmentation

Regionally, the global over-the-counter drugs market has been segmented into North AmericaEuropeAsia PacificRest of the World

Over-the-counter drugs market is highly competitive and comprises several major players. North America holds the leading position in the global over-the-counter drugs market, owing to its well-established healthcare structure, followed by Europe, owing to growing patient awareness involving the consumption of OTC drugs, and managing self-medication practices. Europe would remain in second place, owing to the region's growing awareness of the availability of over-the-counter drugs. Asia Pacific is expected to grow rapidly because of the increasing presence of numerous reputed manufacturers. Rising awareness among the population regarding the use of OTC drugs to treat minor health issues such as cold, cough, and headache is driving the growth of OTC drugs market in this region. Moreover, the increasing prevalence of obesity, the growing aging population, and incessant new product launches by the players in the region are boosting the market growth.

Report Scope & Segmentation: Report CoverageDetails

Market Size in 2021USD ~ 169.1 billion

Revenue forecast in 2030USD ~ 410.48 billion

Growth RateCAGR of ~ 8.2% from 2022 to 2030

Base year for estimation2021

Forecast period2022-2030

Segments coveredProducts, Distribution Channel

Regional scopeNorth America, Europe, Asia Pacific, and the Rest of the World (ROW)

VALUE PROPOSITIONS RELATED TO THE REPORT: Powered with Complimentary Analyst Hours and Expert Interviews with Each ReportComprehensive quantitative and qualitative insights at segment and sub-segment levelCovid 19 impact trends and perspectiveGranular insights at global/regional/country levelDeep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environmentBlanket coverage on competitive landscapeWinning imperativesExhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS: Distributor Landscape AssessmentPricing IntelligenceCustomer Base AssessmentInvestment & Initiatives Analysis'Business Profile' of Key Players

Request for customization of this research report at: https://growthplusreports.com/inquiry/customization/over-the-counter-drugs-market/7735

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

(c) 2022 Global Data Point. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.